- Compound Remdesivir
- Class Antiviral
- Human Studies Yes
- FDA Approved Yes
Drug repurposing has formed a major part of the response to the COVID-19 pandemic and a number of broad-spectrum and specific antiviral inhibitors continue to be examined.
Remdesivir: a nucleotide analogue prodrug that inhibits the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2.
RELATED PROJECTS
